Axcelis Technologies, Inc. (NASDAQ:ACLS - Get Free Report) has earned an average recommendation of "Hold" from the five research firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and one has issued a buy recommendation on the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $148.67.
Several brokerages have recently weighed in on ACLS. Craig Hallum downgraded Axcelis Technologies from a "buy" rating to a "hold" rating and set a $140.00 target price for the company. in a research note on Friday, August 7th. Weiss Ratings raised shares of Axcelis Technologies from a "hold (c-)" rating to a "hold (c)" rating in a research note on Friday, October 16th.
Check Out Our Latest Research Report on Axcelis Technologies
Institutional Trading of Axcelis Technologies
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Reinhart Partners LLC. increased its position in shares of Axcelis Technologies by 14.2% during the third quarter. Reinhart Partners LLC. now owns 1,060,636 shares of the semiconductor company's stock worth $139,134,000 after purchasing an additional 131,976 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in Axcelis Technologies by 0.4% in the 1st quarter. Dimensional Fund Advisors LP now owns 844,097 shares of the semiconductor company's stock valued at $78,565,000 after purchasing an additional 3,057 shares in the last quarter. The Manufacturers Life Insurance Company lifted its holdings in Axcelis Technologies by 3,402.5% in the 1st quarter. The Manufacturers Life Insurance Company now owns 491,745 shares of the semiconductor company's stock valued at $45,772,000 after purchasing an additional 477,705 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in Axcelis Technologies during the 2nd quarter worth $38,830,000. Finally, Principal Financial Group Inc. boosted its stake in Axcelis Technologies by 5.1% during the 1st quarter. Principal Financial Group Inc. now owns 210,202 shares of the semiconductor company's stock worth $19,566,000 after purchasing an additional 10,177 shares during the last quarter. Hedge funds and other institutional investors own 89.98% of the company's stock.
Axcelis Technologies Stock Down 1.5%
Shares of ACLS stock opened at $112.02 on Friday. Axcelis Technologies has a twelve month low of $73.60 and a twelve month high of $193.78. The stock has a market cap of $3.46 billion, a P/E ratio of 37.59, a P/E/G ratio of 3.47 and a beta of 1.86. The stock has a 50 day moving average of $119.01 and a 200 day moving average of $122.66. The company has a current ratio of 4.90, a quick ratio of 3.21 and a debt-to-equity ratio of 0.04.
Axcelis Technologies (NASDAQ:ACLS - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The semiconductor company reported $1.06 EPS for the quarter, topping the consensus estimate of $0.89 by $0.17. The business had revenue of $215.18 million for the quarter, compared to analyst estimates of $205.03 million. Axcelis Technologies had a return on equity of 11.69% and a net margin of 10.71%. The business's quarterly revenue was up 10.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.13 EPS. Axcelis Technologies has set its Q3 2026 guidance at 1.110-1.110 EPS. As a group, sell-side analysts expect that Axcelis Technologies will post 3.39 EPS for the current year.
Axcelis Technologies Company Profile
(
Get Free Report)
Axcelis Technologies, Inc develops and manufactures equipment used in the fabrication of semiconductor devices. The company is best known for its ion implantation systems, which precisely introduce dopant atoms into silicon wafers to control the electrical properties of semiconductor components.
Its product portfolio includes the Purion family of ion implantation systems, designed for applications such as high-current, medium-current and high-energy implantation. Axcelis also provides related aftermarket products and services, including spare parts, equipment upgrades, process support and customer training.
Headquartered in Beverly, Massachusetts, Axcelis serves semiconductor manufacturers and other customers in major chip-production regions worldwide.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axcelis Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axcelis Technologies wasn't on the list.
While Axcelis Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.